期刊文献+

胡桃醌对宫颈鳞癌Caski细胞增殖及凋亡作用的研究 被引量:3

Proliferation inhibition and apoptosis induction of Juglone on human cervical cancer Caski cells
原文传递
导出
摘要 目的探讨胡桃醌对宫颈鳞癌Caski细胞增殖及其促凋亡作用的影响,并对其促凋亡的机制进行初步探究。方法选取处于对数生长期的Caski细胞将其分为空白对照组和不同剂量(20、40、60、80和100 mol/L)胡桃醌组,共6组。采用MTT法观察胡桃醌对Caski细胞的抑制作用,并计算出半数抑制浓度(IC50=42.4μmol/L),依据IC50确定胡桃醌的有效浓度;电镜观察40μmol/L胡桃醌对Caski细胞凋亡的形态学特征,Western blot检测凋亡相关蛋白Bcl-2及Bax的表达。结果 MTT试验显示,与对照组比较,除20μmol/L的胡桃醌外,其他各浓度组差异均有统计学意义(P<0.05,P<0.01);电镜下可见凋亡细胞及凋亡小体,Western blot检测显示与正常对照组相比,40μmol/L胡桃醌Bcl-2表达明显降低而Bax表达明显增加(P<0.05)。结论胡桃醌可以抑制Caski的增殖,并诱导细胞凋亡。 Objective To explore the effects of Juglone on proliferation and apoptosis of human cervical cancer Caski cells, and to further study the related mechanism of cell apoptosis. Methods Cultured Caski cells were incubated with 20,40,60,80 and 100 μmol/L juglone for 24 h. The proliferation of Caski cells was detected by methyl thiazolyl tetrazolium (MTT)assay. The cell apoptosis were detected by transmission electron microscope. The expression of Bcl-2 and Bax were detected by Western blot. Results MTT results showed that in different doses of juglone groups, the Caski cell growth was greatly inhibited (P 〈 0.05, P 〈 0.01 ) and showed dose dependent when compared with control group except 20 μ mol/L. The IC50 of juglone was 42.4 p, mol/L. After treatment on Caski cells with 40μmol/L juglone , typicalapoptosis characteristics was observed by transmission electronmicro scope. The expression of Bcl-2 was decreased while the expression of Bax was increased significantly when compared with control group ( P 〈 0.05). Conclusion Juglone significantly inhibits the proliferation and induces the apoptosis of Caski cells in vitro.
机构地区 吉林医药学院
出处 《卫生研究》 CAS CSCD 北大核心 2014年第6期959-961,971,共4页 Journal of Hygiene Research
基金 国家自然科学基金(No.21102055) 吉林省科技厅科技发展项目(No.20130101157JC) 吉林省教育厅"十二五"教育技术研究项目(No.2014-371 No.2011-286) 吉林市科技局发展项目(No.2013625028)
关键词 胡桃醌 细胞增殖 细胞凋亡 宫颈鳞癌 Juglone,cell proliferation,cell apoptosis, cervical cancer
  • 相关文献

参考文献12

  • 1万志强,李薇,崔久嵬,徐效益,孙景娟,刘军.胡桃醌对白血病细胞增殖的抑制作用[J].吉林大学学报(医学版),2012,38(3):486-489. 被引量:9
  • 2GAVA B, BHARGAVE M C , WESFALLB A. Antimmor activity of Juglans nigra (black walnut) Extractives [ J ]. Pharm Sci, 1968, 57 ( 10 ) : 1674-1677.
  • 3VARGA Z, BENE L, PIERI C,ct al. The effect of Juglone Oil the membrane potential and whole-cell K- currents of human lymphocytes[J]. Biochem Biophys Res Commun, 1996,218 ( 3 ) : 828-832.
  • 4LI Zhibo , WANG Jingyun, JIANG Bo, et al. Benzobijuglone, a novel cytotoxic compound from Juglans mandshurica, induced apoptosis in HeLa cervical cancer cells [ J ]. Phytomedicine, 2007, 14 (12) :846-852.
  • 5MOVSESYAN V A,STOICA B A,YAKOVLEV A G, et al. Anan damide-induced cell death inprimary neuronal cultures role of calpain-and-caspase pathways[ J]. Cell Death Differ, 2004, 11 (10) : 1121-1226.
  • 6张巍,赵行宇,李妍,等.不同浓度的胡桃醌对HeLa细胞的细胞凋亡作用的影响[J].解放军医学杂志,2012,38(2):13-16.
  • 7ZHANG Wei, LIU Anheng , LI Yan, et al. Anticancer activity and mechanism of Juglone on human cervical carcinoma HeLa ceils [ J ]. Can J Physiol Pharmacol,2012, 90 : 553-1558.
  • 8LEE Y M, SHIN S Y, JUE S S,et,al. The role of PIN1 on odontogenic and adipogenic differentiatiqn in human dental pulp stem cells [ J ]. Stem Ceils Dev, 2014 ,23 (6) :618-630.
  • 9CHAO S H, GREENLEAF A L, PRICE D H. Juglone,an inhibitor of the peptidyl-prolyl isomerase Pinl, also directly blocks transcription [ J]. Nucleic Acids Res,2001,29 ( 3 ) : 767-773.
  • 10GONZALEZ-MARTIN A. Molecular biology of cervical cancer [ J ]. Clin Transl Oncol, 2007, 9 (6) :347-354.

二级参考文献20

  • 1易岚,曾希,苏琦,周建国,葛玲,解娜,黄炎,石莺.二烯丙基二硫启动人白血病HL-60细胞凋亡模型的建立[J].中国药理学通报,2007,23(9):1250-1253. 被引量:9
  • 2SETCHELL K D. Soy isoflavones--benefits and risks from nature's selective estrogen receptor modulators (SERMs) [Jl. J Am Coll Nutr, 2001, 20 (5 Suppl) :354S-362S.
  • 3STEINER C, ARNOULD S, SCALBERT A, et al. Isoflavones and the prevention of breast and prostate cancer: new perspectives opened by nutrigenomies [J]. BrJ Nutr, 2008, 99 (ESI):ES78-108.
  • 4UPADHYAY S, NEBURI M, CHINNI S R, et al. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21 (WAF1) [ J]. Clin Cancer Res, 2001, 7 (6): 1782-1789.
  • 5LI P, LIN J E, SCHULZ S. Can eolorectal cancer be prevented or treated by oral hormone replacement therapy? [ J] Curr Mol Pharmacol, 2009, 2 (3) : 285 -292.
  • 6ZHANGY, LIQ, ZHOU D, CHEN H. Genistein, a soya isoflavone, prevents azoxymethane-induced up- regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats [ J ]. Br J Nutr, 2013, 109(1 ) :33-42.
  • 7YAN L, SPITZNAGEL E L, BOSLAND M C. Soy consumption and colorectal cancer risk in humans: a meta-analysis [ J ]. Cancer Epidemiol Biomarkers Prey, 2010, 19(1 ) :148-158.
  • 8ZHANG Z, WANG C Z, DUG J, et al. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells[J]. Int J Oncol, 2013, 43(1):289-296.
  • 9ZHANG X, LI J, SEJAS D P, et al. The ATM/p53/ p21 pathway influences cell fate decision between apoptosis and senescence in reoxygenated hematopoietie progenitor cells [ J ]. J Biol Chem, 2005,280 ( 20 ) : 19635 -19640.
  • 10ESTAQUIER J, VALLETTE F, VAYSSIERE J L, et al. The mitochondrial pathways of apoptosis [ J ]. Adv Exp Med Biol, 2012(942):157-183.

共引文献13

同被引文献39

  • 1冉翠香,高兴盛,师亚波,赵林芳,杨卫民.酶法辅助超声波微波仪从胡桃青皮中提取胡桃醌的工艺研究[J].氨基酸和生物资源,2014,36(1):73-76. 被引量:6
  • 2Sugie S, Okamoto K, Rahman KM, et al. Inhibitory effects ofplumbagin and juglone on azoxymethane-induced intestinalcarcinogenesis in rats[J]. Cancer Lett, 1998 ,127 (1 ) : 177-183.
  • 3Chao SH , Greenleaf AL, Price DH. Juglone, an inhibitor of thepeptidyl-prolyl isomerase Pinl , also directly blocks transcription[J]. Nucleic Acids Res, 2001,29(3):767-773.
  • 4Varga Z, Bene L,Pieri C,et a). The effect of Juglone Oil themembrane potential and whole-cell K-currents of humanlymphocytes[ J]. Biochem Biophys Res Commun, 1996,218(3):828-832.
  • 5Xu HL,Yu XF, Qu SC , et al. Anti-proliferative effect of Juglonefrom Juglans mandshurica Maxim on human leukemia cell HL-60 byinducing apoptosis through the mitochondria-dependent pathway[J]. Eur J Pharmacol, 2010,645(1-3) : 14-22.
  • 6Jing X,Jun B , Xifeng Sh , et al. Proliferation inhibition of humancervical cancer HeLa cells by casticin in vitro [J] . Chinese-GermanJournal of Clinical Oncology ,201 ,10(1) : 47 -50.
  • 7Malaguti C , Ciminiello P, Fattorusso E, et al. Caspase activationand death induced by yessotoxin in HeLa cells [ J ] . Toxicol InVitro, 2002,16(4) :357-363.
  • 8Zhang W, Liu A, Li Y, et al. Anticancer activity and mechanismof juglone on human cervical carcinoma HeLa cells [ J ] . Can JPhysiol Pharmacol, 2012,90(11 ) :1553-1558.
  • 9Tan ML, Ooi JP, Ismail N , et al. Programmed cell death pathwaysand current antitumor targets [ J ] . Pharm Res,2009,26 ( 7 ):1547-1560.
  • 10Datta SR, Dudek H,Tao X,et al. Akt phosphorylation of BADcouples survival signals to the cell-intrinsic death machinery [ J ].Cell, 1997,91(2) : 231-241.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部